Comfort Systems USA (FIX) stock jumps on near-$12 billion backlog, dividend hike
Comfort Systems USA shares jumped 6% Friday after reporting fourth-quarter net income of $330.8 million and
Lam Research stock jumps on BofA top-pick call; Nvidia earnings are the next catalyst
Lam Research shares climbed 2.4% to $243.19 Friday after BofA Securities reiterated a Buy rating and forecast $135 billion in 2026 wafer fabrication equipment spending. Nvidia, Applied Materials, and KLA also rose
Netflix stock climbs on Warner Bros bidding deadline — what traders are watching next
Netflix shares rose 1.6% to $78.25 Friday as investors watched its $27.75-a-share bid for Warner Bros’ studios and streaming assets. Paramount’s rival
Bank of America stock today: BAC ticks up as $25 billion private-credit push lands on a nervous market
Bank of America shares rose 0.4% to $52.96 Friday after Reuters reported the bank is setting aside $25 billion for private-credit deals.
Lithium price ticks up, but these stocks split as fresh writedown and spending plan land
Sibanye Stillwater took a $152.6 million impairment on its Keliber lithium project, while Lithium Americas raised its 2026 Thacker Pass capex estimate
Brent crude price hovers near six-month high as U.S.-Iran deadline keeps oil traders on edge
Brent crude slipped 0.27% to $71.47 a barrel in afternoon London trade but remained up 5.3% for the week. Traders cited U.S.-Iran
Oil prices cling to six-month highs as Trump weighs Iran strike; Brent above $71
Oil prices slipped Friday but held near six-month highs, with Brent at $71.47 and U.S. WTI at $66.29 by late morning. Tensions over Iran and the Strait of Hormuz kept markets volatile, as Trump said he was considering a limited military strike. U.S. crude inventories fell by 9 million barrels last week. OPEC+ meets March 1 to review supply policy.
FTSE 100 today: UK shares end at record close on upbeat data, tariff ruling
The FTSE 100 closed up 59.85 points at 10,686.89 on Friday, topping its previous record, after strong UK retail sales and a
XRP price today rises as hot US inflation data and White House crypto talks collide
XRP rose about 2% to $1.43, trading between $1.38 and $1.44 in the past 24 hours, with $2.5 billion in volume, according
Nvidia stock edges up on reported $30 billion OpenAI stake as AI shares churn
Nvidia rose 0.3% to $188.54 after reports it is nearing a $30 billion investment in OpenAI. Alphabet gained 4.2% and Meta climbed
Grail stock plunges almost 50% after NHS trial misses key goal for Galleri cancer test
Grail shares plunged 49.5% to $51.26 by midday Friday after its NHS-Galleri trial missed the primary endpoint of reducing stage III-IV cancers.
India stock market today: Nifty, Sensex rebound despite oil jitters; Feb 27 GDP reset in focus
Indian shares closed higher Friday, with the Nifty 50 up 0.46% and the Sensex gaining 0.38%, after late profit-taking trimmed earlier gains. The rupee fell to 90.9825 per U.S. dollar, its steepest weekly drop in over a month. Novartis India surged nearly 20% after Novartis agreed to sell its majority stake for $159 million. India VIX rose to 14.36, near an eight-month high, as volatility persisted.
Dow Jones slips as tariff-ruling rally fades; inflation data keeps Wall Street cautious
The Dow fell 141 points by midday Friday, erasing early gains after the U.S. Supreme Court struck down Trump’s global tariffs. The court ruled 6-3 that Trump exceeded his authority, but left refund questions unresolved. Slower GDP growth and higher core inflation weighed on rate-cut hopes. Treasury yields stayed firm amid uncertainty over potential tariff refunds.
Eli Lilly stock slips in New York: why Barclays’ $1,350 call isn’t lifting LLY yet
Eli Lilly shares dropped 1.6% to $1,006.78 Friday morning, underperforming the S&P 500 ETF’s 0.6% gain. Barclays began coverage with an Overweight rating and a $1,350 target, citing strong prospects for GLP-1 weight-loss drugs. Novo Nordisk’s U.S. shares fell 1.9%. Lilly reported new data showing long-term remission with Omvoh in Crohn’s disease and announced a $100 million deal with CSL for clazakizumab rights.
Akamai (AKAM) stock drops as memory costs bite guidance; Wall Street watches capex, pricing
Akamai shares dropped 9.3% to $99.38 Friday after the company warned of higher memory costs and issued a weaker-than-expected first-quarter profit outlook. CEO Tom Leighton said memory prices have “probably doubled” due to AI infrastructure demand. Fourth-quarter revenue rose 7% to $1.095 billion, with security revenue up 11%. Akamai forecast 2026 capital spending at 23% to 26% of revenue.
JPMorgan Chase stock price today: JPM edges up as ECB fine, Trump case and insider sale hit the tape
JPMorgan Chase shares rose 0.2% to $308.60 Friday as the S&P 500 and Nasdaq climbed after the U.S. Supreme Court struck down Trump’s global tariffs. The European Central Bank fined JPMorgan’s European arm €12.18 million for misreporting capital requirements. JPMorgan and CEO Jamie Dimon challenged Trump’s $5 billion lawsuit over closed accounts. Co-CEO Troy Rohrbaugh sold 50,000 shares on Feb. 19.
Nebius stock swings again as Friday slide cools a $150-target rally
Nebius Group shares fell 4.7% to $102.50 in late-morning Nasdaq trade Friday, reversing gains from a two-day rally. Compass Point began coverage with a Buy rating and $150 target. CoreWeave, another AI infrastructure firm, dropped about 9%. Nebius has been spending heavily to expand data centers and counts Microsoft and Meta as customers.
Johnson & Johnson stock slips as $20 billion DePuy sale talk grows — what investors watch next
Johnson & Johnson shares fell 2.1% to $241.75 in late-morning New York trading after reports the company is considering a sale of its DePuy Synthes orthopedics unit, valued at over $20 billion. The company also announced plans to invest more than $1 billion in a new cell therapy manufacturing facility in Pennsylvania.
Oracle (ORCL) stock slides as OpenAI’s $100 billion fundraise and Nvidia earnings loom
Oracle shares dropped 2.7% to $152.25 Friday morning, trailing a broader market rally after the U.S. Supreme Court struck down Trump-era tariffs. Nvidia is nearing a $30 billion investment in OpenAI as part of a funding round topping $100 billion, a source said. Investors are watching for Nvidia’s results next week for signals on AI spending and data-center expansion.
Robinhood stock rises as January trading data shows bigger deposits, but Goldman trims target
Robinhood shares rose 2.3% to $77.39 Friday after reporting $4.5 billion in January net deposits and $324 billion in platform assets. Funded accounts reached 27.2 million, up 190,000 from December. Equity trading volumes climbed 21% to $227.3 billion, while crypto volumes rose 8%. Goldman Sachs cut its price target to $111 from $130.
AMD stock dips on Crusoe $300 million AI-chip loan backstop report as Nvidia earnings loom
AMD shares fell 0.3% to $202.73 Friday after reports the company will backstop a $300 million Goldman Sachs loan for AI cloud startup Crusoe to buy AMD chips. The deal would see AMD lease back hardware if Crusoe fails to find customers. Nvidia shares were little changed. Investors are focused on Nvidia’s earnings next week amid questions about real AI demand.
CoreWeave stock slides nearly 8% as insider sales and data-center funding jitters hit CRWV
CoreWeave shares dropped 8% to $89.40 Friday after hitting a session low of $87.91, as funding concerns surfaced around a $4 billion data center project in Pennsylvania. SEC filings showed Chief Development Officer Brannin McBee sold 166,645 shares under a pre-arranged plan. Investors await CoreWeave’s quarterly results next week. A securities class action is pending against the company over alleged data-center delays.
Meta stock rises as Zuckerberg faces jury questions and report flags fresh cost cuts
Meta Platforms shares rose 1.4% to $653.84 Friday morning after CEO Mark Zuckerberg testified in a youth social media addiction trial in Los Angeles. The Financial Times reported Meta trimmed most employee stock awards by about 5% as it increases AI spending. Meta declined to comment. The company expects 2026 capital expenditures of $115 billion to $135 billion.
Why Alphabet’s GOOG stock is up today: Gemini 3.1 Pro rollout and a new AI shopping deal
Alphabet Class C shares rose 2.1% to $309.87 in early Friday trading after Google launched Gemini 3.1 Pro in preview for enterprise and developer customers. Google and Sea announced a partnership to build an AI shopping prototype for Shopee. U.S. stocks opened lower after GDP data missed forecasts and inflation ran hot.
Micron Technology stock (MU) rises as AI infrastructure trade keeps memory chips in play ahead of March earnings
Micron shares rose 2.7% to $428.49 Friday morning, lifted by tight supply and rising prices for high-end AI memory chips. Needham raised its price target to $450, citing strong demand and fully allocated HBM capacity for 2026. Samsung reportedly plans to hike HBM4 chip prices by up to 30%. Investors await Micron’s March 19 earnings for updates on pricing and supply.
Nvidia stock rises on OpenAI stake report as earnings loom
Nvidia shares rose 0.4% to $188.6 after a source said it is near a $30 billion investment in OpenAI, which seeks over $100 billion at an $830 billion valuation. The deal would replace an earlier plan tied to OpenAI buying Nvidia systems, with most funds expected to purchase Nvidia chips. Nvidia reports earnings Feb. 25, with options markets pricing in a 7% swing. Investors are watching for signs of sustained AI spending.
Oceaneering stock drops 4% as 2026 cash-flow outlook cools the earnings pop
Oceaneering International shares dropped about 4% to $34.74 Friday after the company forecast 2026 free cash flow of $100 million to $120 million, down from $191 million in the fourth quarter. Fourth-quarter revenue fell 6% to $669 million, missing estimates, while adjusted earnings beat forecasts at 45 cents per share. Management warned of a slower first quarter as energy activity remains weak.
Blue Owl’s Private Credit Withdrawal Clampdown Rattles Markets After $1.4B Loan Sale
Blue Owl Capital shares fell about 4% in premarket trading Friday after the firm halted quarterly withdrawals in a retail debt fund and moved to sell $1.4 billion in loans to fund payouts. The stock is down more than 36% in 2025. Blue Owl said it would return 30% of OBDC II’s value to investors within 45 days, replacing a previous quarterly redemption process.
Sasol share price steadies near a 52-week high after an 11% jump, with interim results next in focus
Sasol shares closed down 0.1% at 142.27 rand Friday after hitting a 52-week high of 149.22 rand, following a 10.9% jump Thursday. Interim results for the six months to Dec. 31 are due Monday, with the company guiding for headline earnings per share to fall 29–40%. Brent crude hovered near six-month highs, while the rand traded at 16.1325 per dollar. Investors await clarity on Sasol’s cash generation and spending.
Apple stock slips as iCloud lawsuit and hot inflation data jolt AAPL in early trade
Apple shares fell 0.4% to $259.49 in early Friday trading, extending losses after West Virginia sued the company over iCloud’s alleged role in child sexual abuse material distribution. Investors also weighed hotter-than-expected inflation data and a tougher outlook for U.S. rate cuts. Apple said it is expanding safety features but denied the move was linked to the lawsuit.
First Majestic Silver stock jumps nearly 10% after record Q4 results, new 2026 output target
First Majestic Silver shares rose 9.6% to $24.78 after the miner posted record quarterly revenue of $463.9 million and net earnings of $105.2 million. The company set 2026 production targets of 13–14 million ounces of silver and 110,000–130,000 ounces of gold. A quarterly dividend of $0.0083 per share will be paid March 16 to holders as of Feb. 27. Spot silver climbed 3.1% to $80.76 an ounce.
Americold Realty Trust stock slips in premarket after 16% earnings surge as 2026 outlook lands
Americold shares fell 1.7% to $13.65 in premarket trading Friday after surging nearly 16% Thursday. The company forecast 2026 AFFO of $1.20 to $1.30 per share, citing industry headwinds. Fourth-quarter results showed $658.5 million in revenue, a net loss of $88.3 million, and economic occupancy dropping to 76.1%. Net debt stood at about $4.2 billion, with leverage at 6.8 times EBITDA.
Texas Pacific Land stock jumps in premarket after record 2025 results, bigger dividend
Texas Pacific Land shares jumped about 10.5% premarket after reporting record full-year revenue of $798.2 million and net income of $481.4 million. The company raised its quarterly dividend by 12.5% and announced a $450.7 million Midland Basin royalty-acre purchase and a $50 million data-center infrastructure investment.
UK PMI hits a 22-month high in February — but job cuts won’t stop
UK flash composite PMI rose to 53.9 in February, the highest since April 2024, as factory output and export orders picked up. Employment fell for a 17th month, with firms citing cost pressures and redundancies. Retail sales jumped 1.8% in January, and the public sector posted a record £30.4 billion surplus. Input costs and selling prices increased, mainly in services.
Stock market today: Dow, S&P 500 futures slide after GDP slows and PCE inflation runs hot
U.S. GDP grew at a 1.4% annual rate in Q4 2025, sharply down from 4.4% the previous quarter, after a government shutdown cut output. S&P 500, Nasdaq 100, and Dow futures all fell before the opening bell. December core PCE inflation rose 0.4% on the month and 3.0% year-over-year, above forecasts. Blue Owl shares dropped 5.9% after its new capital-return plan.
Herbalife stock price today: HLF slips premarket after 18% surge on earnings, Ronaldo Pro2col stake
Herbalife shares fell 0.6% to $19.46 premarket Friday after surging 18.3% to a 52-week high in the prior session. The company forecast 2026 net sales growth of 1%–6% and adjusted EBITDA of $670–$710 million. Cristiano Ronaldo invested $7.5 million for a 10% stake in Pro2col Software. China and North America sales declined in the fourth quarter.